Kallista Prima is primarily engaged in pharmaceuticals activity. Its headquarters is located in Dki Jakarta. The company was founded in 1983. Kallista Prima is a prominent player in the Indonesian pharmaceutical industry, known for its commitment to quality and innovation in healthcare solutions. The company was founded by a group of visionary entrepreneurs who aimed to address the growing healthcare needs in Indonesia. Over the years, Kallista Prima has expanded its operations to include a wide range of pharmaceutical products, focusing on both prescription and over-the-counter medications. The company operates several branches across Indonesia, ensuring a strong local presence and accessibility to its products. Kallista Prima's product portfolio includes a variety of therapeutic categories, such as antibiotics, cardiovascular drugs, and pain management solutions. Some of its well-known brands have become household names in the Indonesian market. In addition to its domestic operations, Kallista Prima has established a footprint in several Southeast Asian countries, exporting its products to markets such as Malaysia, Thailand, and the Philippines. The company is actively involved in partnerships with international pharmaceutical firms to enhance its research and development capabilities. Kallista Prima is a member of several industry associations, which helps it stay at the forefront of pharmaceutical advancements and regulatory standards. The company is committed to sustainable practices and aims to improve healthcare outcomes through innovative and affordable solutions. With a vision to be a leading pharmaceutical company in the region, Kallista Prima continues to invest in cutting-edge technologies and strategic collaborations to expand its product offerings and reach.
Headquarters
Komplek IAPCO, Jl. Kemang Timur Raya No.26, RT.012 RW.08
South Jakarta; Jakarta;
Postal Code: 12510
Contact Details: Purchase the PT Kallista Prima report to view the information.
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service